Sign in

CIK 0001021561

  • Accelerated filer

NU SKIN ENTERPRISES, INC.

Sign in to watch
Ticker
NUS
Exchange
NYSE
Industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870565309
Phone
+1 801-345-1000
Business address
75 WEST CENTER ST, ATTN: GREGORY BELLISTON, PROVO, UT, 84601
Former names
NU SKIN ENTERPRISES INC, NU SKIN ASIA PACIFIC INC, NU SKIN ASIA INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-07 CAMPBELL DANIEL W Director Grant or award +4,232 18,924
2023-06-07 Battle Emma S. Director Grant or award +4,232 8,891
2023-06-05 Hatchett Steven Keith Chief Product Officer Shares withheld for taxes −462 $33.74 $16K 57,906
2023-06-05 Clark Chayce David EVP and General Counsel Shares withheld for taxes −979 $33.74 $33K 100,399
2023-05-25 LIPMAN ANDREW D Director Sale −2,000 $34.28 $69K 58,393
2023-05-09 WOODBURY EDWINA D Director Sale −1,255 $37.87 $48K 15,469
2023-04-25 LIPMAN ANDREW D Director Sale −2,000 $40.75 $82K 60,393
2023-04-21 Tang Connie Mang Yee Chief Global Growth Officer Shares withheld for taxes −1,120 $41.37 $46K 43,204
2023-03-31 Thomas James D Interim CFO Grant or award +6,360 24,288
2023-03-27 LIPMAN ANDREW D Director Sale −2,000 $39.29 $79K 62,393
2023-03-13 Battle Emma S. Director Other acquisition +15 $40.00 $600 7,686
2023-03-09 Hatchett Steven Keith Chief Product Officer Exercise or conversion +21,155 $30.45 $644K 79,523
2023-03-09 Hatchett Steven Keith Chief Product Officer Sale −21,155 $39.78 $842K 58,368
2023-03-09 Hatchett Steven Keith Chief Product Officer Exercise or conversion · Employee Stock Option (Right to Buy) −21,155 5,602
2023-03-08 WOODBURY EDWINA D Director Grant or award +15 $39.74 $596 16,724
2023-03-02 Lawrence Mark H Chief Financial Officer Exercise or conversion +18,041 $30.45 $549K 83,290
2023-03-02 Lawrence Mark H Chief Financial Officer Sale −26,144 $40.80 $1.1M 57,146
2023-03-02 Lawrence Mark H Chief Financial Officer Exercise or conversion · Employee Stock Option (Right to Buy) −18,041 100,000
2023-03-02 CHANG JOSEPH Y Chief Scientific Officer Exercise or conversion +600 $30.63 $18K 21,834
2023-03-02 CHANG JOSEPH Y Chief Scientific Officer Exercise or conversion +24,400 $30.45 $743K 46,234

Page 8 of 15 · 288 trades